353 related articles for article (PubMed ID: 27078869)
21. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure.
Mattos BR; Bonacio GF; Vitorino TR; Garcia VT; Amaral JH; Dellalibera-Joviliano R; Franca SC; Tanus-Santos JE; Rizzi E
Biochem Pharmacol; 2020 Oct; 180():114121. PubMed ID: 32592722
[TBL] [Abstract][Full Text] [Related]
22. Quercetin decreases the activity of matrix metalloproteinase-2 and ameliorates vascular remodeling in renovascular hypertension.
Pereira SC; Parente JM; Belo VA; Mendes AS; Gonzaga NA; do Vale GT; Ceron CS; Tanus-Santos JE; Tirapelli CR; Castro MM
Atherosclerosis; 2018 Mar; 270():146-153. PubMed ID: 29425960
[TBL] [Abstract][Full Text] [Related]
23. Antioxidant tempol modulates the increases in tissue nitric oxide metabolites concentrations after oral nitrite administration.
Ferreira GC; Pinheiro LC; Oliveira-Paula GH; Angelis CD; Portella RL; Tanus-Santos JE
Chem Biol Interact; 2021 Nov; 349():109658. PubMed ID: 34543659
[TBL] [Abstract][Full Text] [Related]
24. Gastric S-nitrosothiol formation drives the antihypertensive effects of oral sodium nitrite and nitrate in a rat model of renovascular hypertension.
Pinheiro LC; Amaral JH; Ferreira GC; Portella RL; Ceron CS; Montenegro MF; Toledo JC; Tanus-Santos JE
Free Radic Biol Med; 2015 Oct; 87():252-62. PubMed ID: 26159506
[TBL] [Abstract][Full Text] [Related]
25. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of nitric oxide synthase induces renal xanthine oxidoreductase activity in spontaneously hypertensive rats.
Laakso J; Vaskonen T; Mervaala E; Vapaatalo H; Lapatto R
Life Sci; 1999; 65(25):2679-85. PubMed ID: 10622277
[TBL] [Abstract][Full Text] [Related]
27. Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension.
Montenegro MF; Pinheiro LC; Amaral JH; Ferreira GC; Portella RL; Tanus-Santos JE
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jun; 387(6):591-8. PubMed ID: 24658348
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol improves vasoprotective effects of captopril on aortic remodeling and fibrosis triggered by renovascular hypertension.
Natalin HM; Garcia AF; Ramalho LN; Restini CB
Cardiovasc Pathol; 2016; 25(2):116-9. PubMed ID: 26764145
[TBL] [Abstract][Full Text] [Related]
29. Dispelling dogma and misconceptions regarding the most pharmacologically targetable source of reactive species in inflammatory disease, xanthine oxidoreductase.
Kelley EE
Arch Toxicol; 2015 Aug; 89(8):1193-207. PubMed ID: 25995007
[TBL] [Abstract][Full Text] [Related]
30. Xanthine Oxidoreductase Function Contributes to Normal Wound Healing.
Madigan MC; McEnaney RM; Shukla AJ; Hong G; Kelley EE; Tarpey MM; Gladwin M; Zuckerbraun BS; Tzeng E
Mol Med; 2015 Apr; 21(1):313-22. PubMed ID: 25879627
[TBL] [Abstract][Full Text] [Related]
31. Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension.
Ceron CS; Castro MM; Rizzi E; Montenegro MF; Fontana V; Salgado MC; Gerlach RF; Tanus-Santos JE
Br J Pharmacol; 2010 May; 160(1):77-87. PubMed ID: 20331602
[TBL] [Abstract][Full Text] [Related]
32. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
Iglarz M; Touyz RM; Viel EC; Amiri F; Schiffrin EL
Am J Hypertens; 2004 Jul; 17(7):597-603. PubMed ID: 15243979
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension.
Guimarães DA; Rizzi E; Ceron CS; Martins-Oliveira A; Gerlach RF; Shiva S; Tanus-Santos JE
Redox Biol; 2015 Dec; 6():386-395. PubMed ID: 26343345
[TBL] [Abstract][Full Text] [Related]
34. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
Sainz J; Wangensteen R; Rodríguez Gómez I; Moreno JM; Chamorro V; Osuna A; Bueno P; Vargas F
Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750
[TBL] [Abstract][Full Text] [Related]
35. Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential.
Ghosh SM; Kapil V; Fuentes-Calvo I; Bubb KJ; Pearl V; Milsom AB; Khambata R; Maleki-Toyserkani S; Yousuf M; Benjamin N; Webb AJ; Caulfield MJ; Hobbs AJ; Ahluwalia A
Hypertension; 2013 May; 61(5):1091-102. PubMed ID: 23589565
[TBL] [Abstract][Full Text] [Related]
36. Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury.
Lu P; Liu F; Yao Z; Wang CY; Chen DD; Tian Y; Zhang JH; Wu YH
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):350-5. PubMed ID: 16109514
[TBL] [Abstract][Full Text] [Related]
37. Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension.
Marçal DM; Rizzi E; Martins-Oliveira A; Ceron CS; Guimaraes DA; Gerlach RF; Tanus-Santos JE
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):35-44. PubMed ID: 21058008
[TBL] [Abstract][Full Text] [Related]
38. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
Rizzi E; Guimaraes DA; Ceron CS; Prado CM; Pinheiro LC; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
Free Radic Biol Med; 2014 Aug; 73():308-17. PubMed ID: 24933619
[TBL] [Abstract][Full Text] [Related]
39. Diuretic herb Gomphrena celosioides Mart. (Amaranthaceae) promotes sustained arterial pressure reduction and protection from cardiac remodeling on rats with renovascular hypertension.
de Paula Vasconcelos PC; Tirloni CAS; Palozi RAC; Leitão MM; Carneiro MTS; Schaedler MI; Silva AO; Souza RIC; Salvador MJ; Junior AG; Kassuya CAL
J Ethnopharmacol; 2018 Oct; 224():126-133. PubMed ID: 29842964
[TBL] [Abstract][Full Text] [Related]
40. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
Bayorh MA; Mann G; Walton M; Eatman D
Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
